首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1633568

感覺異常治療市場規模、佔有率和成長分析（按疾病類型、適應症、藥物類別、配銷通路、最終用戶和地區）- 行業預測，2025-2032 年

Paresthesia Treatment Market Size, Share, Growth Analysis, By Disorder Type (Acute Paresthesia, Chronic Paresthesia), By Indication (Radiculopathy, Neuropathy), By Drug Class, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月11日 | 出版商:

SkyQuest | 英文 203 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球感覺異常治療市場規模價值 55 億美元，預計將從 2024 年的 57.1 億美元成長到 2032 年的 76.9 億美元，預測期內（2025-2032 年）的複合年成長率為 3.8%。

感覺異常的特徵是身體各部位，特別是手腳出現灼熱、刺痛或麻木感，越來越被認為是各種醫療問題的重要指標。這種情況的根源在於神經損傷、壓迫和血流不暢，通常預示著潛在的問題，例如第 1 型和第 2 型糖尿病、維生素缺乏、神經病變和腕隧道症候群。隨著對這些相關性的認知不斷提高，對治療解決方案的需求也日益成長，針對感覺異常原因的診斷和治療的潛在市場機會也日益增加。醫療保健提供者和製藥公司可以利用這個市場，開發標靶治療和患者教育資源來有效解決這種複雜的情況，為經歷這種痛苦情況的患者提供更好的管理選擇。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益與前一年同期比較（2022-2024 年）

主要企業簡介

Medtronic plc（Ireland）
Boston Scientific Corporation（United States）
Abbott Laboratories（United States）
Nevro Corp.（United States）
Stryker Corporation（United States）
Pfizer Inc.（United States）
GlaxoSmithKline plc（United Kingdom）
Baxter International Inc.（United States）
Glenmark Pharmaceuticals Ltd.（India）
Omron Healthcare, Inc.（United States）
Stimwave LLC（United States）
Cyberonics, Inc.（United States）
EnteroMedics Inc.（United States）
Bio-Medical Research Ltd.（United Kingdom）
Sanofi SA（France）
Bristol-Myers Squibb Company（United States）
Johnson & Johnson（United States）
Novartis International AG（Switzerland）
AstraZeneca plc（United Kingdom）

結論和建議

簡介目錄

Product Code: SQMIG35A2802

Global Paresthesia Treatment Market size was valued at USD 5.5 billion in 2023 and is poised to grow from USD 5.71 billion in 2024 to USD 7.69 billion by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).

Paresthesia, characterized by sensations like burning, tingling, and numbness in various body parts (especially hands and feet), is increasingly recognized as a significant indicator of various medical issues. Rooted in nerve damage, compression, or impaired blood flow, this condition often signals underlying problems, including type 1 and type 2 diabetes, vitamin deficiencies, neurological disorders, and carpal tunnel syndrome. As awareness of these correlations grows, there is a potential market opportunity for diagnostics and treatments targeting the causes of paresthesia, alongside increased demand for therapeutic solutions. Healthcare providers and pharmaceutical companies could capitalize on this market by developing targeted therapies and patient education resources to address this complex condition effectively, enhancing management options for patients experiencing these distressing symptoms.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Paresthesia Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Paresthesia Treatment Market Segmental Analysis

Global Paresthesia Treatment Market is segmented by Disorder Type, Indication, Drug Class, Distribution Channel, End User and region. Based on Disorder Type, the market is segmented into Acute Paresthesia and Chronic Paresthesia. Based on Indication, the market is segmented into Radiculopathy and Neuropathy. Based on Drug Class, the market is segmented into Anticonvulsants, Immunosuppressants, Antidepressants, Opioids and Other. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on End User, the market is segmented into Hospitals, Clinics and Diagnosis Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Paresthesia Treatment Market

The global market for paresthesia treatment is significantly driven by the rising prevalence of chronic illnesses, including diabetes, neuropathy, and autoimmune disorders. These medical conditions often lead to paresthesia, which is marked by abnormal sensations like tingling and numbness. As paresthesia frequently indicates underlying health issues, the demand for effective management and treatment options is escalating. Furthermore, with more individuals undergoing anesthesia procedures, healthcare professionals must cater to the growing population of patients experiencing anesthesia-related complications, further amplifying the need for innovative and accessible solutions in the paresthesia treatment market.

Restraints in the Global Paresthesia Treatment Market

Restraints in the Global Paresthesia Treatment market include the potential adverse effects linked to specific therapies. Patients undergoing treatments like nerve stimulation or chemotherapy may encounter reactions such as discomfort or complications, which could hinder their acceptance of these methods. Concerns regarding safety and tolerability significantly impact both patient and physician willingness to adopt these interventions. Furthermore, the variability in individual responses to treatments poses a unique challenge for healthcare professionals, who must thoughtfully consider and customize treatment plans for each patient to ensure optimal outcomes, emphasizing the importance of a mindful and personalized approach in managing paresthesia.

Market Trends of the Global Paresthesia Treatment Market

The Global Paresthesia Treatment market is witnessing a significant upward trend, primarily fueled by the rising prevalence of neurological disorders like multiple sclerosis, diabetic neuropathy, and carpal tunnel syndrome. As the global population ages, the susceptibility to conditions such as strokes and other neurological diseases is increasing, intensifying the demand for effective anesthetic treatments. Furthermore, technological advancements in therapeutic devices, including transcutaneous electrical stimulation (TENS) and ultrasound devices, are enhancing treatment efficacy and patient outcomes. This convergence of demographic shifts and innovation in treatment modalities is expected to propel substantial growth in the paresthesia treatment market throughout the forecast period.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis

Global Paresthesia Treatment Market Size by Disorder Type & CAGR (2025-2032)

Market Overview
Acute Paresthesia
Chronic Paresthesia

Global Paresthesia Treatment Market Size by Indication & CAGR (2025-2032)

Market Overview
Radiculopathy
Neuropathy

Global Paresthesia Treatment Market Size by Drug Class & CAGR (2025-2032)

Market Overview
Anticonvulsants
Immunosuppressants
Antidepressants
Opioids
Other

Global Paresthesia Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Paresthesia Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Clinics
Diagnosis Centers

Global Paresthesia Treatment Market Size & CAGR (2025-2032)

North America (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- US
- Canada
Europe (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Disorder Type, Indication, Drug Class, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glenmark Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stimwave LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EnteroMedics Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Medical Research Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments